Argyle Capital Management Inc. Decreases Stock Holdings in MetLife, Inc. (NYSE:MET)

Argyle Capital Management Inc. reduced its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 19.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,525 shares of the financial services provider’s stock after selling 9,200 shares during the period. Argyle Capital Management Inc.’s holdings in MetLife were worth $2,482,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in MET. Strategic Blueprint LLC grew its stake in shares of MetLife by 4.1% during the 3rd quarter. Strategic Blueprint LLC now owns 5,467 shares of the financial services provider’s stock valued at $344,000 after buying an additional 217 shares during the period. CX Institutional increased its holdings in MetLife by 12.0% during the 3rd quarter. CX Institutional now owns 5,386 shares of the financial services provider’s stock worth $339,000 after purchasing an additional 577 shares during the last quarter. Oak Thistle LLC bought a new position in MetLife during the 3rd quarter valued at $397,000. Simplicity Solutions LLC raised its stake in MetLife by 4.3% during the third quarter. Simplicity Solutions LLC now owns 25,830 shares of the financial services provider’s stock valued at $1,625,000 after buying an additional 1,055 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in MetLife by 84.1% in the third quarter. Valeo Financial Advisors LLC now owns 12,320 shares of the financial services provider’s stock worth $775,000 after purchasing an additional 5,629 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on MET shares. Wells Fargo & Company increased their price objective on shares of MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Morgan Stanley raised their price objective on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Keefe, Bruyette & Woods lifted their price target on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 10th. The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and upped their price target for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Finally, UBS Group reduced their price objective on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a research report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $79.23.

View Our Latest Stock Report on MET

MetLife Trading Down 2.1 %

Shares of MET traded down $1.48 during trading hours on Friday, hitting $70.42. 5,650,572 shares of the stock were exchanged, compared to its average volume of 2,506,510. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.68. The business has a 50-day moving average of $71.44 and a 200-day moving average of $67.22. The firm has a market capitalization of $50.92 billion, a P/E ratio of 38.48, a price-to-earnings-growth ratio of 0.53 and a beta of 1.04. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The business had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, research analysts expect that MetLife, Inc. will post 8.71 EPS for the current year.

MetLife Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.10%. This is a boost from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, May 6th. MetLife’s dividend payout ratio is presently 113.66%.

Insider Activity

In other news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the transaction, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by company insiders.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.